NICOLE URBON: Open Payments
NPI 1851154017 · BIG RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $741 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $68 |
| Stryker Corporation | 1 | $63 |
| Astellas Pharma US Inc | 3 | $60 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: OPTABLATE, Veozah, VRAYLAR, NURTEC ODT, REXULTI, UBRELVY, TZIELD, COBENFY.
Industry payments across MI — which companies pay providers there.
